| Name | Title | Contact Details |
|---|---|---|
Mel Eisele |
Vice President / Client Services | Profile |
Novocardia is on a mission to transform how cardiovascular disease care is delivered in the United States, and aims to help patients with heart and vascular disease live longer, healthier, and more satisfying lives. We are committed to putting cardiologists, and their patients, at the center of care by investing in our partner practices, deploying purpose-built data and analytics tools to improve patient outcomes, and enabling our partners to transition more successfully to value-based care.
Obagi Medical Products, Inc. is a Long Beach, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
RSi Communications Group is a Hackensack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Providence St Joseph Medical Center is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.